Amgen Inc. (NASDAQ:AMGN) is one of the cheap NASDAQ stocks to buy right now. On May 19, Amgen announced the retirement of its Executive Vice President and Chief Financial Officer, Peter Griffith, who has held the role since 2020. During his tenure, Griffith was instrumental in strengthening the company’s financial position, supporting capital allocation, and driving its long-term growth strategy.
Thomas Dittrich has been named as Griffith’s successor. He will return to Amgen on July 1 as Executive Vice President, transitioning into the Chief Financial Officer role on September 1. Dittrich brings over 30 years of international experience in the biopharmaceutical and healthcare sectors, including previous CFO roles at Galderma, Shire, and Sulzer.
To ensure a seamless leadership transition, Griffith will remain with the company through January 2027. Dittrich will oversee all aspects of the firm’s financial operations, continuing Amgen’s focus on delivering long-term growth and patient-centered care.
Amgen Inc. (NASDAQ:AMGN) is a drug manufacturer that delivers human therapeutics through pharmaceutical wholesale distributors. The company was founded in 1980 and is headquartered in California.
While we acknowledge the potential of AMGN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy.
Disclosure: None. Follow Insider Monkey on Google News.
